Ramucirumab for patients with advanced HCC and elevated alpha-fetoprotein following non-sorafenib-based therapy: interim results from phase 3 REACH-2 expansion cohort

Finn, Richard C; De Toni, Enrico N; Chung Cheung Yau, Thomas; Yen, Chia-Jui; Hsu, Chih-Hung; Chan, Stephen L; He, Aiwu Ruth; Galle, Peter; Trojan, Jörg; Stirnimann, Guido; Baron, Ari; Rivera, Mirelis Acosta; Goyal, Lipika; Wang, Chunxiao; Abada, Paolo; Widau, Ryan; Zhu, Andrew X (November 2020). Ramucirumab for patients with advanced HCC and elevated alpha-fetoprotein following non-sorafenib-based therapy: interim results from phase 3 REACH-2 expansion cohort. In: SOHC 2020 - Swiss Oncology & Hematology Congress - 3rd; Online Conference. November 18 - 21, 2020.

[img] Text
Poster_SOHC_2020_0_78.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (862kB)

Item Type:

Conference or Workshop Item (Poster)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology

UniBE Contributor:

Stirnimann, Guido

Subjects:

600 Technology > 610 Medicine & health

Language:

English

Submitter:

Rahel Fuhrer

Date Deposited:

08 Jan 2021 14:16

Last Modified:

08 Jan 2021 14:16

BORIS DOI:

10.48350/151000

URI:

https://boris.unibe.ch/id/eprint/151000

Actions (login required)

Edit item Edit item
Provide Feedback